SEI Investments’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Other funds holding STOK
LCM
SEI Investments's STOK Position: Q3 2026 in Review
SEI Investments increased its Stoke Therapeutics (STOK) stake by 37% in Q3 2026, buying an estimated $98.5K and bringing the position to 12,066 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #2843.
SEI Investments first reported a position in STOK in Q3 2025 and has held it in 5 quarters since. The position peaked at $528K in Q4 2025. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.
- SEI Investments held 12,066 shares of Stoke Therapeutics worth $314K as of Q3 2026.
- SEI Investments bought 3,262 Stoke Therapeutics shares in Q3 2026, an estimated $98.5K.
- Stoke Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2843 holding.
- SEI Investments first reported a position in Stoke Therapeutics in Q3 2025 and has held it in 5 quarters since.
- SEI Investments's Stoke Therapeutics position peaked at $528K in Q4 2025.
- 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.